Business
cbdMD Reports 19% Year-over-Year and 12% Sequential Revenue Growth; Bluebird Acquisition Integration and Medicare BEI Pathway Position Company for Continued Momentum
cbdMD, Inc. (NYSE American: YCBD), one of the nation's leading and most trusted CBD companies and operator of the cbdMD, Bluebird Botanicals, and Paw CBD brands, along with its THC beverage brand Oasis, today announced financial results for the second quarter of fiscal year 2026, ended March 31, 2026.
About this update from Cbdmd, Inc.
[{"type":"text","content":"CHARLOTTE, N.C. , May 14, 2026 /PRNewswire/ -- cbdMD, Inc. (NYSE American: YCBD), one of the nation's leading and most trusted CBD companies and operator of the cbdMD, Bluebird Botanicals, and Paw CBD brands, along with its THC beverage brand Oasis, today announced financial results for the second quarter of fiscal year 2026, ended March 31, 2026.","length":358,"tagName":"p"},{"type":"image","alt":"cbdMD logo (PRNewsfoto/cbdMD, Inc.)","displaySize":"","headline":null,"caption":"cbdMD logo (PRNewsfoto/cbdMD, Inc.)","className":"","disableSlideshowImg":false,"size":{"original":{"width":400,"height":172,"url":"https://media.zenfs.com/en/prnewswire.com/39be855165955bdcbd347db26f31394c"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/1WsfRLZvEpvHr45sjmqUow--/YXBwaWQ9aGlnaGxhbmRlcjt3PTcwNTtoPTMwMw--/https://media.zenfs.com/en/prnewswire.com/39be855165955bdcbd347db26f31394c","width":400,"height":172},"resize_sm":{"url":"https://s.yimg.com/ny/api/res/1.2/d692.w3b06VkevgDm.4inQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTY0MDtoPTI3NQ--/https://media.zenfs.com/en/prnewswire.com/39be855165955bdcbd347db26f31394c","width":400,"height":172}},"href":"https://mma.prnewswire.com/media/2829180/cbdMD_Logo.html","hrefExternal":true,"rel":"nofollow"},{"type":"text","content":"The Company delivered 19% year-over-year and 12% sequential revenue growth, reflecting continued momentum in the core business and the contribution of newly acquired Bluebird Botanicals. Quarterly revenue, excluding revenue associated with the Bluebird acquisition, was the highest since our first fiscal quarter ending December 2023.","length":334,"tagName":"p"},{"type":"text","content":""This was a quarter of meaningful execution on multiple fronts," said Ronan Kennedy, CEO and CFO of cbdMD. "Our core business delivered another quarter of consistent growth, we successfully completed and integrated our first acquisition in years. The Bluebird Botanicals acquisition is a case study for what we can do — leveraging our infrastructure, marketing engine, and NYSE American listing to unlock value in a fragmented industry — and it sets the template for additional roll-up opportunities across hemp and adjacent health and wellness categories."","length":577,"tagName":"p"},{"type":"text","content":""At the same time, the regulatory backdrop has shifted more in the l...